Search results
Halozyme Therapeutics Scores RS Rating Jump To 91
Investor's Business Daily· 3 days agoOn Friday, Halozyme Therapeutics stock earned an upgrade to its Relative Strength (RS) Rating, from 80 to 91. See if the biotech stock forms a new...
Halozyme stock hits 52-week on guidance raise (NASDAQ:HALO)
Seeking Alpha· 4 days agoHalozyme Therapeutics (HALO) stock gains as company raises full-year outlook after securing a new...
Halozyme's (HALO) ENHANZE Product Gets New Patent Grant in EU
Zacks via Yahoo Finance· 4 days agoHalozyme (HALO) is set to benefit from the new patent grant in the EU, ensuring the protection of...
Halozyme Therapeutics (NASDAQ:HALO) Updates FY24 Earnings Guidance
ETF DAILY NEWS· 2 days agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $3.65-4.05 ...
Halozyme stock downgraded to neutral, price target raised By Investing.com
Investing.com· 3 days agoOn Friday, Piper Sandler adjusted its stance on Halozyme (NASDAQ:HALO) Therapeutics (NASDAQ:HALO),...
Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 4 days agoIt has been about a month since the last earnings report for Halozyme Therapeutics (HALO). Shares...
Halozyme Announces Issuance of New European Patent for ENHANZE® Drug Delivery Platform
StreetInsider· 5 days agoConference Call Scheduled for Thursday, June 6 at 5:30am PT/8:30am ET SAN...
Halozyme Therapeutics +13% On Thursday: What's Going On? - Halozyme Therapeutics (NASDAQ:HALO)
Benzinga· 4 days agoHalozyme Therapeutics surges as it raises FY24 guidance, driven by increased revenue projections and a new European patent for its drug delivery platform.
Dow Jones Rises After Jobless Claims; Nvidia Falls On Planned Stock Sale As Halozyme Tops Growth...
Investor's Business Daily· 4 days agoThe Dow Jones and other indexes were mixed on the stock market today after initial jobless claims....
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Zacks via Yahoo Finance· 6 days agoHalozyme Therapeutics (HALO) San Diego, CA-based Halozyme Therapeutics is a biopharmaceutical...